Información adicional

• Num_publicacion 74(9)
• Resumen_ingles
  Introduction: The impact on society of the pharmacotherapy associated with attention deficit hyperactivity disorder (ADHD), invites one to reflect upon the efficiency of current therapeutical strategies. A pharmacoenocomic evaluation is hereby presented in order to quantify the savings associated with the partial substitution of extended release methylphenidate (ER-MPH) for Immediate release methylphenidate (IR-MPH).
  Methods: A cost-minimization analysis was performed, from the perspective of the Spanish National Health System (SNS by its acronym in Spanish), in a time-span of 3 years. The analysis included IR-MPH and the different ER-MPH options available in Spain; assuming equivalent effectiveness among them. The results are presented as the medication’s direct cost for the SNS. These results were subsequently extended with a budgetary impact analysis (BIA) over 7 years –using an approximated mean of ER-MPH cost.
  Results: Each patient treated with ER-MPH has an estimated average annual cost of € 343.90, compared with € 91.80 with IR-MPH. Considering a low substitution rate of ER-MPH for IR-MPH (5%), the accumulated savings for the SNS in a period of 3 years would be 4.1 M €. Following a substitution policy of +5% a year, until reaching +25%, would generate an accumulated savings of € 23.7 M; exceeding the SNS’ current yearly investment in MPH (€ 20,9M).
  Conclusions: Given its low acquisition cost, the increase in the use of IR-MPH would suppose important savings for the SNS. However, other factors should also be considered when implementing this proposal.
   
• Palabras_clave_ingles Direct costs Budgetary impact Methylphenidate Cost minimization National Health System Attention deficit hyperactivity disorder
• Todos_autores T.W. Jiménez Rodríguez¹, A. Martí Gil²
• autores listados T.W. Jiménez Rodríguez, A. Martí Gil
• Correspondecia
  T.W. Jiménez Rodríguez. Sección de Alergología. Hospital General de Alicante. C/ Pintor Baeza, 12, planta 8. 03010 Alicante.
  Correo electrónico: twjresearch@gmail.com
• Titulo_ingles Analysis of cost minimizing impact on the budget of the National Health System for attention deficit hyperactivity disorder treatment with immediate release in place of different extended release methylphenidate alternatives
• Centros_trabajo ¹Pediatra en consulta privada. Cartagena (Murcia) ²Clever Instruments, S.L. Barcelona
• Publicado en Acta Pediatr Esp. 2016; 74(9): 209-216
• copyright ©2016 Ediciones Mayo, S.A.
• Fecha recepcion 12/07/16
• Fecha aceptacion 18/10/16
• Tipo de Artículo Clínico (Microdatos) Observational Study